Literature DB >> 27134912

Diabetic Kidney Disease and Hypertension: A True Love Story.

Anand Verma1, Sony Vyas2, Abhishek Agarwal2, Shahid Abbas3, Devi Prasad Agarwal4, Ravindra Kumar5.   

Abstract

INTRODUCTION: Diabetes Mellitus (DM) remains one of the commonest causes of structural and functional kidney abnormalities leading to End Stage Renal Disease (ESRD). The next most common cause is hypertension. It is utmost important to investigate the association between diabetic nephropathy and hypertension because it is a major causal factor of end-stage kidney failure in Type 2 Diabetes Mellitus (T2DM). AIM: The aim of the present study was to investigate the association between albuminuria, hypertension and estimated glomerular filtration rate (eGFR) in a prospective cohort of T2DM patients in a developing country.
MATERIALS AND METHODS: A total of 824 patients were enrolled from a tertiary healthcare center in central India. This study was performed in three groups: normal controls (232), type 2 diabetics without nephropathy (185) and type 2 diabetics with nephropathy (407). Diabetic nephropathy was clinically defined by the presence of persistent proteinuria of > 500mg/day in a diabetic patient in the absence of clinical or laboratory evidence of other kidney or urinary tract disease. Hypertension was categorized based on JNC 7 classification. Detailed clinical history was obtained from all subjects. Student's t-test was applied to see the difference in mean values of quantitative data in two groups. Chi-Square test was applied to see the difference in frequency of discrete variables in two groups.
RESULTS: A 66.3% diabetic nephropathy patients and 51.9% type 2 diabetics without nephropathy were found hypertensive in present study; In contrast only 14.7% controls had hypertension. No association of hypertension was found with age and gender in either group. Serum creatinine and eGFR was found significantly different in hypertensive diabetic nephropathy patients than normotensive (p=0.002 and <0.0001 respectively).
CONCLUSION: Our study found that hypertension was an independent risk factor for the Diabetic Kidney Disease (DKD). Along with this, a proportional increase in the level of serum creatinine and eGFR was seen with an incidence of hypertension in diabetic nephropathy.

Entities:  

Keywords:  Diabetes; Diabetic nephropathy; Proteinuria

Year:  2016        PMID: 27134912      PMCID: PMC4843298          DOI: 10.7860/JCDR/2016/18806.7511

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

2.  Nephropathy in newly diagnosed type 2 diabetics with special stress on the role of hypertension.

Authors:  Navneet Agarwal; N S Sengar; P K Jain; Rashi Khare
Journal:  J Assoc Physicians India       Date:  2011-03

Review 3.  Albumin--an important extracellular antioxidant?

Authors:  B Halliwell
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

4.  Serum albumin and blood pressure: a population-based, cross-sectional study.

Authors:  Arne T Høstmark; Sissel E Tomten; John E Berg
Journal:  J Hypertens       Date:  2005-04       Impact factor: 4.844

Review 5.  Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.

Authors:  Peter N Van Buren; Robert Toto
Journal:  Adv Chronic Kidney Dis       Date:  2011-01       Impact factor: 3.620

6.  Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study.

Authors:  Bessie A Young; Wayne J Katon; Michael Von Korff; Greg E Simon; Elizabeth H B Lin; Paul S Ciechanowski; Terry Bush; Malia Oliver; Evette J Ludman; Edward J Boyko
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

7.  Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

Authors:  H H Parving; M A Gall; P Skøtt; H E Jørgensen; H Løkkegaard; F Jørgensen; B Nielsen; S Larsen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

8.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

9.  Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population.

Authors:  Priyanka Shankarishan; Prasanta Kumar Borah; Giasuddin Ahmed; Jagadish Mahanta
Journal:  Biomed Res Int       Date:  2014-08-06       Impact factor: 3.411

10.  Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease.

Authors:  R Shanmuganathan; R Kumaresan; P Giri
Journal:  J Postgrad Med       Date:  2015 Oct-Dec       Impact factor: 1.476

View more
  5 in total

1.  Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus.

Authors:  Fan Hu; Taotao Zhang
Journal:  Int J Gen Med       Date:  2020-07-06

2.  Development and Validation of a Model That Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.

Authors:  Jing Yang; Sheng Jiang
Journal:  Int J Gen Med       Date:  2022-05-20

Review 3.  Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature.

Authors:  Nemanja Rancic; Viktorija Dragojevic-Simic; Neven Vavic; Aleksandra Kovacevic; Zoran Segrt; Natasa Djordjevic
Journal:  Front Public Health       Date:  2016-08-31

4.  Decreased GFR and its joint association with type 2 diabetes and hypertension with prevalence and severity of carotid plaque in a community population in China.

Authors:  Qianzi Che; Ying Yang; Guanliang Cheng; Jia Jia; Fangfang Fan; Jianping Li; Yong Huo; Dafang Chen; Yan Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-26       Impact factor: 3.168

5.  Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece.

Authors:  Ilias N Migdalis; Nikolaos Papanas; Ioannis M Ioannidis; Alexios E Sotiropoulos; Athanasios E Raptis; George D Dimitriadis
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.